Clinical Trial Update: Study of the Use of Nasal IFN-γ in Patients for the Prevention of Acute Respiratory Viral Infections, Icluding COVID-19 [NA]

View source ↗

Summary

Completed clinical trial evaluating nasal interferon gamma for prevention of acute respiratory viral infections, including COVID-19; results were posted on 2024…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Disease

Drugs mentioned

• Nasal interferon gamma (interferon gamma)

Snippet

Sponsor: SPP Pharmaclon Ltd. | Conditions: COVID-19 Respiratory Infection, Acute Respiratory Disease | NA | Status: COMPLETED | Results posted: 2024-08-09